197 related articles for article (PubMed ID: 11698290)
21. Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells.
Lagneaux L; Delforge A; De Bruyn C; Bernier M; Bron D
Leuk Lymphoma; 1999 Nov; 35(5-6):445-53. PubMed ID: 10609782
[TBL] [Abstract][Full Text] [Related]
22. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
23. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
24. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
[TBL] [Abstract][Full Text] [Related]
25. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
Filip AA; Ciseł B; Wąsik-Szczepanek E
Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
[TBL] [Abstract][Full Text] [Related]
26. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
27. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription.
Buggins AG; Pepper C; Patten PE; Hewamana S; Gohil S; Moorhead J; Folarin N; Yallop D; Thomas NS; Mufti GJ; Fegan C; Devereux S
Cancer Res; 2010 Oct; 70(19):7523-33. PubMed ID: 20736369
[TBL] [Abstract][Full Text] [Related]
28. CD5 does not regulate the signaling triggered through BCR in B cells from a subset of B-CLL patients.
Perez-Chacon G; Vargas JA; Jorda J; Alvarez N; Martin-Donaire T; Rosado S; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Lymphoma; 2007 Jan; 48(1):147-57. PubMed ID: 17325858
[TBL] [Abstract][Full Text] [Related]
29. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival.
Ghia P; Boussiotis VA; Schultze JL; Cardoso AA; Dorfman DM; Gribben JG; Freedman AS; Nadler LM
Blood; 1998 Jan; 91(1):244-51. PubMed ID: 9414291
[TBL] [Abstract][Full Text] [Related]
30. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
Granziero L; Circosta P; Scielzo C; Frisaldi E; Stella S; Geuna M; Giordano S; Ghia P; Caligaris-Cappio F
Blood; 2003 Mar; 101(5):1962-9. PubMed ID: 12406905
[TBL] [Abstract][Full Text] [Related]
31. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
32. NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.
Lee HH; Dadgostar H; Cheng Q; Shu J; Cheng G
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9136-41. PubMed ID: 10430908
[TBL] [Abstract][Full Text] [Related]
33. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
34. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
[TBL] [Abstract][Full Text] [Related]
35. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells.
Barragán M; Bellosillo B; Campàs C; Colomer D; Pons G; Gil J
Blood; 2002 Apr; 99(8):2969-76. PubMed ID: 11929788
[TBL] [Abstract][Full Text] [Related]
36. High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia.
Morales AA; Olsson A; Celsing F; Osterborg A; Jondal M; Osorio LM
Int J Cancer; 2005 Feb; 113(5):730-7. PubMed ID: 15499630
[TBL] [Abstract][Full Text] [Related]
37. Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma.
Chiron D; Dousset C; Brosseau C; Touzeau C; Maïga S; Moreau P; Pellat-Deceunynck C; Le Gouill S; Amiot M
Oncotarget; 2015 Apr; 6(11):8750-9. PubMed ID: 25797245
[TBL] [Abstract][Full Text] [Related]
38. Biology of the neoplastic lymphocyte in B-CLL.
Dighiero G
Baillieres Clin Haematol; 1993 Dec; 6(4):807-20. PubMed ID: 8038491
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells.
Wong SC; Chew WK; Tan JE; Melendez AJ; Francis F; Lam KP
J Biol Chem; 2002 Aug; 277(34):30707-15. PubMed ID: 12070149
[TBL] [Abstract][Full Text] [Related]
40. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
